Recent research from the University of Bristol has established a direct link between being overweight and an increased risk of developing dementia later in life. The study suggests that millions of dementia cases could potentially be prevented through effective weight management and blood pressure control. While previous studies had identified correlations between midlife obesity (BMI of 30 or higher) and memory-related conditions, it was unclear whether these associations were causal or influenced by other lifestyle factors such as smoking or unmanaged hypertension.

Published in The Journal of Clinical Endocrinology and Metabolism, the study identifies a causal relationship between higher BMI and vascular dementia, a form of dementia resulting from impaired blood flow to the brain. This damage often occurs due to the narrowing or blockage of small blood vessels, sometimes triggered by a stroke, which ultimately leads to the death of brain cells. Dr. Ruth Frikke-Schmidt, a chief physician and age-related disease expert, emphasized, “In this study we found high BMI and high blood pressure are direct causes of dementia. The treatment and prevention of elevated BMI and high blood pressure represent an unexploited opportunity for dementia prevention.”

Evidence from Large-Scale Genetic Studies

The study analyzed data from over 500,000 participants in Copenhagen and the UK, employing a Mendelian Randomisation approach. This allowed researchers to examine the impact of genetic variants associated with BMI independently of lifestyle factors. Individuals genetically predisposed to higher BMI were found to have a greater likelihood of developing vascular dementia. Around a quarter of this risk was linked to high blood pressure, highlighting the importance of managing hypertension to reduce dementia risk. Dr. Frikke-Schmidt noted that these factors are not merely warning signs but direct, actionable causes of dementia.

Dr. Liv Tybjærg Nordestgaard, lead author of the Copenhagen study, highlighted the global impact of dementia, affecting 50 million people worldwide with limited treatment and prevention options. She added, “Our study highlights the potential for reducing vascular-related dementia risk by addressing high BMI and/or high blood pressure in the population.” This is particularly relevant as two in three Britons are currently overweight or obese, a trend linked to brain changes, increased Alzheimer’s risk, type 2 diabetes, and high blood pressure among younger adults.

Public Health Implications and Prevention

The advent of weight-loss medications such as Mounjaro and Wegovy has revolutionized obesity treatment, delivering significant weight reduction and cardiometabolic benefits. However, Dr. Frikke-Schmidt cautioned that it is still unknown whether these drugs, if administered before cognitive symptoms appear, can prevent dementia. Studies have shown that such interventions do not halt early cognitive decline in Alzheimer’s, although they may temporarily improve blood pressure and metabolic markers.

In parallel, a panel of leading experts has released 56 evidence-based recommendations for dementia prevention. These include managing blood pressure and delivering clear, actionable public health messages. Experts recommend straightforward guidance such as, “Losing weight could reduce the risk of dementia,” to avoid overwhelming individuals with technical jargon or causing feelings of blame.

The global burden of dementia continues to grow. In the UK, around 900,000 people currently live with dementia, with numbers expected to exceed 1.6 million by 2040. Vascular dementia is the second most common form after Alzheimer’s, and dementia is the leading cause of death in the UK, responsible for over 74,000 deaths annually. In the US, an estimated 6.7 million Americans aged 65 and older currently live with dementia, a figure projected to reach nearly 14 million by2060, with approximately 120,000 deaths each year attributed solely to Alzheimer’s.

This compelling evidence underscores the importance of proactive public health interventions targeting modifiable risk factors like obesity and hypertension, offering a critical opportunity to mitigate the growing dementia crisis worldwide.